FDA Drugs recall ·

Sofosbuvir and Velpatasvir, 400 mg/100 mg tablets… recall

Recall number
D-0313-2025
Date
(initiated March 7, 2025)
Company / brand
Asegua Therapeutics LLC
333 Lakeside Dr, Foster City, CA, United States
Category
Drugs › Class II
Classification
Class II
Status
Terminated
Units affected
18,541 cartons.
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Sofosbuvir and Velpatasvir, 400 mg/100 mg tablets, 28 tablets: 2x14 blister cards, Rx Only, Manufactured for: Asegua Therapeutics LLC an affiliate of Gilead Sciences, Inc., Foster City, CA 94404, Made in Ireland, NDC# 72626-2701-1

Why was it recalled?

Defective Container: blister packs not properly sealed resulting in tablets being loose in the carton.

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Lot# 24ASV002UA, Exp Date: 6/30/2028

Distribution

US Nationwide

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (drugs), recall D-0313-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.